Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Neogenex — Predicate Candidate Screening
20 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
111 daysmedian FDA review time
231 days90th percentile
20clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K965047 | MINK LUNG CELL CULTURE | Neogenex | 1997-02-04 | 48 | 0 |
| K960909 | H292 CELL CULTURE | Neogenex | 1996-05-30 | 86 | 0 |
| K943887 | HUMAN NEWBORN FORESKIN CELL CULTURE | Neogenex | 1994-11-28 | 111 | 0 |
| K943891 | RD CULTURE CELL | Neogenex | 1994-11-28 | 111 | 0 |
| K943885 | PRIMARY RABBIT KIDNEY CELL CULTURE | Neogenex | 1994-11-28 | 111 | 0 |
| K943889 | VERO CELL CULTURE | Neogenex | 1994-11-28 | 111 | 0 |
| K943884 | PRIMARY MONKEY KIDNEY CELL CULTURE | Neogenex | 1994-11-28 | 111 | 0 |
| K943890 | WI38 CELL CULTURE | Neogenex | 1994-11-28 | 111 | 0 |
| K943888 | MDCK CELL CULTURE | Neogenex | 1994-11-28 | 111 | 0 |
| K943886 | BGM CELL CULTURE | Neogenex | 1994-11-28 | 111 | 0 |
| K941714 | CHLAMYDIA TRACHOMATIS ANTIGEN TEST | Neogenex | 1994-07-18 | 117 | 0 |
| K942172 | INFLUENZA A ANTIGEN TEST | Neogenex | 1994-07-06 | 62 | 0 |
| K942174 | INFLUENZA B ANITGEN TEST | Neogenex | 1994-06-30 | 56 | 0 |
| K942173 | RSV ANTIGEN TEST | Neogenex | 1994-06-30 | 56 | 0 |
| K942171 | CMV EARLY ANTIGEN TEST | Neogenex | 1994-06-30 | 56 | 0 |
| K933927 | HEP-2 CULTURE CELL | Neogenex | 1994-03-31 | 233 | 0 |
| K933923 | A549 CULTURE CELL | Neogenex | 1994-03-29 | 231 | 0 |
| K933924 | MCCOY CULTURE CELL | Neogenex | 1994-03-29 | 231 | 0 |
| K933925 | MRC-5 CULTURE CELL | Neogenex | 1994-03-29 | 231 | 0 |
| K933926 | LLCMK2 CULTURE CELLS | Neogenex | 1994-03-29 | 231 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda